Know Cancer

or
forgot password

Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer


N/A
21 Years
N/A
Open (Enrolling)
Both
Hepatitis B,Chronic, Carcinoma,Hepatocellular

Thank you

Trial Information

Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer


Inclusion Criteria:



- Patients of at least 21 years old on day of giving consent for study

- Patients must be able and wiling to give an informed consent

- Patient with chronic HBV infection

- Patient with active hepatocellular carcinoma and chronic hepatitis B

- Healthy subjects

Exclusion Criteria:

- Patients who have co-infection with HIV or chronic hepatitis C

- Subjects with other types of cancer

Type of Study:

Observational

Study Design:

Time Perspective: Cross-Sectional

Authority:

Malaysia: Ministry of Health

Study ID:

09-317-3991

NCT ID:

NCT01310062

Start Date:

August 2010

Completion Date:

August 2012

Related Keywords:

  • Hepatitis B,Chronic
  • Carcinoma,Hepatocellular
  • hepatocellular carcinoma
  • microarray
  • gene expression profiling
  • biomarkers
  • Carcinoma
  • Hepatitis
  • Hepatitis A
  • Hepatitis B
  • Liver Neoplasms
  • Hepatitis B, Chronic
  • Carcinoma, Hepatocellular

Name

Location